GGHCX vs. FBTCX
Compare and contrast key facts about Invesco Health Care Fund (GGHCX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX).
GGHCX is managed by Invesco. It was launched on Aug 6, 1989. FBTCX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
GGHCX vs. FBTCX - Performance Comparison
Loading graphics...
GGHCX vs. FBTCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GGHCX Invesco Health Care Fund | -6.17% | 15.48% | 3.96% | 3.05% | -13.53% | 12.05% | 14.52% | 32.01% | 0.27% | 15.51% |
FBTCX Fidelity Advisor Biotechnology Fund Class C | 2.09% | 38.48% | -2.00% | 9.86% | -8.64% | -3.72% | 31.17% | 24.82% | -4.55% | 24.81% |
Returns By Period
In the year-to-date period, GGHCX achieves a -6.17% return, which is significantly lower than FBTCX's 2.09% return. Over the past 10 years, GGHCX has underperformed FBTCX with an annualized return of 7.04%, while FBTCX has yielded a comparatively higher 10.32% annualized return.
GGHCX
- 1D
- 2.71%
- 1M
- -5.49%
- YTD
- -6.17%
- 6M
- -0.07%
- 1Y
- 5.67%
- 3Y*
- 6.01%
- 5Y*
- 2.87%
- 10Y*
- 7.04%
FBTCX
- 1D
- 5.09%
- 1M
- -0.81%
- YTD
- 2.09%
- 6M
- 15.10%
- 1Y
- 54.26%
- 3Y*
- 17.00%
- 5Y*
- 6.73%
- 10Y*
- 10.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
GGHCX vs. FBTCX - Expense Ratio Comparison
GGHCX has a 1.04% expense ratio, which is lower than FBTCX's 1.75% expense ratio.
Return for Risk
GGHCX vs. FBTCX — Risk / Return Rank
GGHCX
FBTCX
GGHCX vs. FBTCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Health Care Fund (GGHCX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GGHCX | FBTCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.29 | 1.90 | -1.60 |
Sortino ratioReturn per unit of downside risk | 0.51 | 2.49 | -1.98 |
Omega ratioGain probability vs. loss probability | 1.06 | 1.32 | -0.26 |
Calmar ratioReturn relative to maximum drawdown | 0.29 | 3.08 | -2.79 |
Martin ratioReturn relative to average drawdown | 0.92 | 12.19 | -11.28 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| GGHCX | FBTCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.29 | 1.90 | -1.60 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.19 | 0.29 | -0.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | 0.42 | -0.02 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.57 | 0.27 | +0.30 |
Correlation
The correlation between GGHCX and FBTCX is 0.79, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
GGHCX vs. FBTCX - Dividend Comparison
GGHCX's dividend yield for the trailing twelve months is around 6.06%, more than FBTCX's 1.65% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GGHCX Invesco Health Care Fund | 6.06% | 5.69% | 5.17% | 0.00% | 0.00% | 24.69% | 6.44% | 3.51% | 8.81% | 6.88% | 2.24% | 15.07% |
FBTCX Fidelity Advisor Biotechnology Fund Class C | 1.65% | 1.68% | 0.00% | 0.00% | 0.00% | 24.50% | 9.78% | 7.92% | 2.92% | 0.00% | 0.00% | 5.73% |
Drawdowns
GGHCX vs. FBTCX - Drawdown Comparison
The maximum GGHCX drawdown since its inception was -40.23%, smaller than the maximum FBTCX drawdown of -64.04%. Use the drawdown chart below to compare losses from any high point for GGHCX and FBTCX.
Loading graphics...
Drawdown Indicators
| GGHCX | FBTCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.23% | -64.04% | +23.81% |
Max Drawdown (1Y)Largest decline over 1 year | -13.53% | -13.63% | +0.10% |
Max Drawdown (5Y)Largest decline over 5 years | -25.37% | -37.26% | +11.89% |
Max Drawdown (10Y)Largest decline over 10 years | -29.34% | -39.37% | +10.03% |
Current DrawdownCurrent decline from peak | -10.60% | -2.75% | -7.85% |
Average DrawdownAverage peak-to-trough decline | -8.82% | -23.21% | +14.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.35% | 3.75% | +0.60% |
Volatility
GGHCX vs. FBTCX - Volatility Comparison
The current volatility for Invesco Health Care Fund (GGHCX) is 5.53%, while Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a volatility of 9.37%. This indicates that GGHCX experiences smaller price fluctuations and is considered to be less risky than FBTCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| GGHCX | FBTCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.53% | 9.37% | -3.84% |
Volatility (6M)Calculated over the trailing 6-month period | 9.39% | 17.02% | -7.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.87% | 25.99% | -10.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.52% | 23.48% | -7.96% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.51% | 24.66% | -7.15% |